LONDON, UK: ValiRx plc, a company developing early-stage cancer therapeutics and women’s health products, has signed a five-year agreement with the University of Dundee and its Drug Discovery Unit (DDU) to access their research on new potential drugs. The first project under the agreement will focus on pro-senescence, a novel approach that aims to make…